Seeking Alpha

Merck (MRK +0.5%) gets a boost out of positive comments out of Barron's yesterday, saying that...

Merck (MRK +0.5%) gets a boost out of positive comments out of Barron's yesterday, saying that promising new drugs and a strong dividend should keep investors buying it for some time to come. Moreover, Barron's adds, headcount reductions and synergies from its Schering-Plough acquisition of have gone a long way towards improving the company's margin and growth outlook. Although the stock is trading near 52-week highs, there still may be some life left in the shares.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|